TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II

Journal of Clinical Investigation

Volumn 109, Issue 6, 2002, Pages 787-796

  Schultz, Jo El J ^a   Witt, Sandra A ^b   Glascock, Betty J ^b   Nieman, Michelle L ^a   Reiser, Peter J ^c   Nix, Stacey L ^a   Kimballand, Thomas R ^b   Doetschman, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; MUSCLE PROTEIN; MYOSIN; RENIN; TRANSFORMING GROWTH FACTOR BETA1; ANGIOTENSIN II; MYOSIN HEAVY CHAIN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FUNCTION; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CARDIOMEGALY; CELL SIZE; CYTOLOGY; DRUG EFFECT; GENETICS; HEART; HEART MUSCLE; HEMODYNAMICS; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CELL SIZE; ECHOCARDIOGRAPHY; HEART; HEMODYNAMIC PROCESSES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYOCARDIUM; MYOSIN HEAVY CHAINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85047682235     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214190     Document Type: Article

References (73)

1. The transforming growth factor-beta family
2. The TGF beta superfamily in myocardium: Ligands, receptors, transduction, and function
3. Strain dependency of TGFbeta 1 function during embryogenesis
4. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
5. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
6. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death
7. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated
8. Analysis of tooth development in mice bearing a TGF-beta 1 null mutation
9. Transforming growth factor beta 1 suppresses genomic instability independent of a G1 arrest, p53, and Rb
10. Transforming growth factor beta 1 enhances platelet aggregation through a non-transcriptional effect on the fibrinogen receptor
11. Transforming growth factor-beta 1 is a new form of tumor suppressor with true haploid insufficiency
12. Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma
13. Transforming growth factor beta 1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis
14. Transforming growth factor beta-1 in acute myocardial infarction in rats
15. Cellular origin and distribution of transforming growth factor-beta in the normal rat myocardium
16. Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes
17. Overexpression of transforming growth factor-beta 1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy
18. Elevated insulin-like growth factor-I and transforming growth factor- beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism
19. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo
20. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development
21. Transforming growth factor-beta in cardiac ontogeny and adaptation
22. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors
23. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen
24. Angiotensin II directly increases transforming growth factor beta 1 and osteopontin and indirectly affects collagen mRNA expression in the human heart
25. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes
26. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
27. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: The CARDI-GENE study
28. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy
29. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts
30. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts
31. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype
32. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression
33. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension
34. The V(D)J recombination activating gene, RAG-1
35. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice
36. End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice
37. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
38. The use of fluorescein isothiocyanate labeled lectins for immuno-histological demonstration of saccharides. III. Studies by use of Ricinus communis lectin and wheat germ agglutinin
39. Transgenic Galphaq overexpression induces cardiac contractile failure in mice
40. Hypoxia-induced regulation of MAPK phosphatase-1 as identified by subtractive suppression hybridization and cDNA microarray analysis
41. Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species
42. Comparison of indices of muscle and pump performance in patients with coronary artery disease
43. Methylprednisolone treatment in acute myocardial infarction. Effect on regional and global myocardial function
44. Comparison of right ventricular impedance, pulse pressure and maximal dP/dt for determination of hemodynamic stability of ventricular arrhythmias associated with coronary artery disease
45. Detection of early abnormalities of left ventricular function by hemodynamic, echo-tissue Doppler imaging, and mitral Doppler flow techniques in patients with coronary artery disease and normal ejection fraction
46. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice
47. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
48. New developments in our knowledge of blood pressure regulation
49. Actions of angiotensin II on the brain: Mechanisms and physiologic role
50. Angiotensin II - An important stress hormone
51. Control of aldosterone secretion
52. Regulation of the epithelial Na+ channel by aldosterone: Open questions and emerging answers
53. Natriuretic peptide signalling: Molecular and cellular pathways to growth regulation
54. Alterations in gene expression in the rat heart after chronic pathological and physiological loads
55. TGF-beta(1) and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy
56. Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts
57. Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts
58. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice
59. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: Effects of inhibition of the renin-angiotensin system
60. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(l) transgene in the heart
61. Myosin isoenzyme redistribution in chronic heart overload
62. Myosin isoenzyme changes in several models of rat cardiac hypertrophy
63. Isozymic changes in myosin of human atrial myocardium induced by overload. Immunohistochemical study using monoclonal antibodies
64. Changes in gene expression during cardiac growth
65. Cardiac myocytes as targets for the action of peptide growth factors
66. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype
67. TGF-beta 1 and fibroblast growth factors selectively up-regulate tissue-specific fetal genes in cardiac muscle cells
68. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium
69. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs
70. Upregulated and downregulated transcription of myocardial genes after pulmonary artery banding in pigs
71. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis
72. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy
73. Myosin heavy chain messenger RNA and protein isoorm transitions during cardiac hypertrophy. Interaction between hemoynamic and thyroid hormone-induced signals